Virtu Financial LLC Vyne Therapeutics Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.24 - $4.27 $809 - $14,406	-3,374 Reduced 5.2%	61,464 $14,000
Q2 2022 Aug 09, 2022	BUY	$0.37 - $0.71 $14,887 - $28,568	40,237 Added 163.56%	64,838 $25,000
Q1 2022 May 17, 2022	SELL	$0.5 - $1.15 $75,338 - $173,278	-150,677 Reduced 85.96%	24,601 $16,000
Q4 2021 Feb 17, 2022	BUY	$0.91 - $1.5 $60,932 - $100,438	66,959 Added 61.82%	175,278 $179,000
Q3 2021 Nov 12, 2021	BUY	$1.39 - $3.47 $150,563 - $375,866	108,319 New	108,319 $151,000
Q2 2021 Sep 17, 2021	SELL	$3.24 - $6.92 $44,057 - $94,098	-13,598 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$6.34 - $12.68 $86,211 - $172,422	13,598 New	13,598 $93,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $184M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.